A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
Clinical trial NCT06959615 · RECRUITING
Trial details
- NCT number
- NCT06959615
- Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-22
- Primary completion
- 2026-12-31
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.